A novel dual regulator of tumor necrosis factor-α and interleukin-10 protects mice from endotoxin-induced shock

European Journal of Pharmacology

Volumn 391, Issue 3, 2000, Pages 317-320

  Fukuda, Tetsuko ^a   Sumichika, Hiroshi ^a   Murata, Meguru ^a   Hanano, Tokushi ^a   Adachi, Kunitomo ^a   Hisadome, Masao ^a  

^a Research Laboratories   (Japan)

Author keywords

Interleukin 10; Lipopolysaccharide; TNF ; Tumor necrosis factor

Indexed keywords

ANTIINFLAMMATORY AGENT; ENDOTOXIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; Y 39041;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

ACETAMIDES; ADMINISTRATION, ORAL; ANIMALS; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PIPERAZINES; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034677806     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00096-0     Document Type: Article

References (8)

1. Beutler B., Milsark I.W., Cerami A. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 229:1985;869-871.
2. Deitch E.A. Animal models of sepsis and shock: a review and lessons learned. Shock. 9:1998;1-11.
3. Fiorentino D.Fet al. Interleukin-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
4. Howard M., Muchamuel S., Andrade S., Menon S. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1993;1205-1208.
5. Kato T.et al. Interleukin 10 reduces mortality from severe peritonitis in mice. Antimicrob. Agents Chemother. 39:1995;1336-1340.
6. Newton R.C., Decicco C.P. Therapeutic potential and strategies for inhibiting tumor necrosis factor-α J. Med. Chem. 42:1999;2295-2314.
7. Perkins D.J., St Clair E.W., Misukonis M.A., Weinberg J.B. Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor α monoclonal antibody (cA2). Arthritis Rheum. 41:1998;2205-2210.
8. Walmsley M., Katsikis P.D., Abrey E., Parry S., Williams R.O., Maini R.N., Feldmann M. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 39:1996;495-503.